Inventor · disambiguated record
Clayton Beard
Also filed as: BEARD CLAYTON · BEARD CLAYTON W
5 granted patents·10 pending applications·8 citations·filing 2014–2024
70Inventor score
Files withPREC BIOSCIENCES INC10ALTRAVAX INC2BRIDGEBIO GENE THERAPY RES INC2ADRENAS THERAPEUTICS INC1
Top patents by PatentIndex Score
15 records- 0191US11053484B2Genetically-modified T cells comprising a modified intron in the T cell receptor alpha genePREC BIOSCIENCES INC·Filed 2018·Granted Jul 6, 2021·5 cites·10 claims
- 0278US2025313816A1Genetically-modified cells comprising a modified transferrin genePREC BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0376US9353158B2Hepatitis B virus vaccinesALTRAVAX INC·Filed 2014·Granted May 31, 2016·3 cites·20 claims
- 0468US12448613B2Genetically-modified T cells comprising a modified intron in the T cell receptor alpha genePREC BIOSCIENCES INC·Filed 2021·Granted Oct 21, 2025·0 cites·20 claims
- 0568US10745665B2Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereofPREC BIOSCIENCES INC·Filed 2019·Granted Aug 18, 2020·0 cites·2 claims
- 0666US2022228115A1Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereofPREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0766US2022193267A1Engineered nucleases useful for treatment of hemophilia aPREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0859US2020339952A1Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereofPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0958US2025114480A1Gene therapy for genetic hearing lossBRIDGEBIO GENE THERAPY RES INC·Filed 2023·Application pending·0 cites
- 1057US11278632B2Engineered nucleases useful for treatment of hemophilia APREC BIOSCIENCES INC·Filed 2017·Granted Mar 22, 2022·0 cites·16 claims
- 1157US2022119786A1Genetically-modified cells comprising a modified transferrin genePREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1255US2025001008A1Gene therapy for galactosemiaBRIDGEBIO GENE THERAPY RES INC·Filed 2022·Application pending·0 cites
- 1353US2020299658A1Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia aPREC BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1444US2024191213A1Gene therapies for 21-hydroxylase deficiencyADRENAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1542US2016229897A1Hepatitis b virus vaccinesALTRAVAX INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clayton Beard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →